Somatostatin and Analogues in the Treatment of VIPoma

@article{Odorisio1988SomatostatinAA,
  title={Somatostatin and Analogues in the Treatment of VIPoma},
  author={T. O'dorisio and T. Gaginella and H. Mekhjian and B. Rao and M. O'dorisio},
  journal={Annals of the New York Academy of Sciences},
  year={1988},
  volume={527}
}
Precedent for natural peptide therapy began with the use of insulin in the treatment of insulin-dependent diabetes mellitus in 1922.’ More recently, we have witnessed the use of interferon, interleukin-2, and tumor necrosis factor (TNF), all naturally occurring peptides in man. Most recently, the novel long-acting analogue of natural somatostatin has become available on a compassionate need basis for refractory, symptomatic endocrine tumors of the gastroenteropancreatic (GEP) axis. SMS… Expand

Topics from this paper

Octreotide: Entering the New Era of Peptidomimetic Therapy
The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?
Systemic treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETS): current approaches and future options.
  • J. Strosberg
  • Medicine
  • Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • 2014
...
1
2
3
...

References

SHOWING 1-10 OF 37 REFERENCES
Somatostatin: historical aspects.
  • S. Reichlin
  • Biology, Medicine
  • Scandinavian journal of gastroenterology. Supplement
  • 1986
Somatostatin: a peptide with unexpected physiologic activities.
  • P. Brazeau
  • Medicine
  • The American journal of medicine
  • 1986
Physiological and pathophysiological aspects of somatostatin.
...
1
2
3
4
...